Related Experiment Videos
Epitope spreading occurs in active but not passive EAE induced by myelin basic protein
R R Voskuhl1, R W Farris, K Nagasato
1Laboratory of Viral and Molecular Pathogenesis, NINDS, National Institutes of Health, Bethesda, MD 20892, USA. rvoskuhl@ucla.edu
Journal of Neuroimmunology
|November 1, 1996
Summary
Epitope spreading, crucial for multiple sclerosis (MS) therapies, was studied in a passive experimental allergic encephalomyelitis (EAE) model. Findings suggest limited epitope spreading occurs in this specific EAE model, unlike active EAE.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
- Central Nervous System (CNS) Inflammation
Background:
- Experimental allergic encephalomyelitis (EAE) models autoimmune demyelinating diseases like multiple sclerosis (MS).
- Epitope spreading, a change in T cell response specificity during disease, is key for MS therapeutic strategies.
- EAE's clinical and pathological outcomes vary with host factors and induction methods.
Purpose of the Study:
- To investigate epitope spreading in a passive EAE model in SJL/J mice, chosen for its clinical and neuropathological similarity to MS.
- To determine if T cell responses broaden to other myelin antigens during disease progression.
- To compare epitope spreading in passive versus active EAE models.
Main Methods:
- Induction of passive EAE using T cells specific for whole 18.5 kDa myelin basic protein (MBP).
- Monitoring T cell responsiveness to immunodominant (MBP 87-106) and subdominant (MBP 16-35) regions, and to proteolipid protein (PLP) 139-151.
- Comparison with active EAE induced by MBP.
Main Results:
- Progressive increase in T cell responsiveness to MBP 87-106 observed.
- No evidence of intermolecular spreading to PLP 139-151 or intramolecular spreading to MBP exon 2.
- No shift in immunodominance towards MBP 16-35.
- Epitope spreading to PLP 139-151 observed in active EAE, but not in passive EAE.
Conclusions:
- Passive EAE induced with whole MBP-specific T cells shows limited epitope spreading.
- Immune responses in passive and active EAE models differ significantly.
- Findings suggest minimal epitope spreading in chronic relapsing demyelinating disease initiated without exogenous antigen or adjuvants.